Shares of monday.com fall as the company's revenue forecast disappoints. ...

Core Insights - monday.com reported Q3 CY2025 revenue of $316.9 million, exceeding Wall Street's expectations by 1.4% with a year-on-year growth of 26.2% [1][7][8] - The company provided Q4 CY2025 revenue guidance of $329 million, which is below analysts' estimates of $333.8 million [1][7] - Non-GAAP profit per share was $1.16, surpassing analysts' consensus estimates by 32.5% [1][7] Company Overview - monday.com is a cloud-based work operating system designed to help teams manage projects, track tasks, and streamline workflows through customizable interfaces [4] Revenue Growth - The company achieved an impressive annualized revenue growth of 53.3% over the last five years, outperforming the average software company [5] - Over the last two years, the annualized revenue growth was 31.2%, indicating healthy demand despite being below the five-year trend [6] Financial Performance - Adjusted operating income was $47.48 million, exceeding analyst estimates by 33.7% with a margin of 15% [7] - Operating margin improved to -0.8%, up from -10.9% in the same quarter last year [7] - Free cash flow margin increased to 28.5%, compared to 21.4% in the previous quarter [7] - The company has 3,993 customers paying more than $50,000 annually, with a net revenue retention rate of 115% [7] Market Position - The current market capitalization of monday.com stands at $9.77 billion [7]

Core Insights - Monday.com reported third-quarter earnings of $1.16 per share, a 36% increase year-over-year, with revenue rising 26% to $316.9 million, surpassing Wall Street expectations for profit but falling short on revenue guidance [2][3] - The company projected revenue of $329 million for the upcoming quarter, below analyst estimates of $333.7 million, indicating a cautious outlook [3] Financial Performance - Adjusted profit for the quarter ending September 30 was $1.16 per share, compared to analysts' expectations of 88 cents [2] - Revenue for the same quarter was $316.9 million, exceeding the forecast of $312.3 million, while the previous year's revenue was $251 million [2] Stock Market Reaction - Following the earnings report, Monday.com's stock fell 18% to approximately $155.49, marking a two-year low [3] - Prior to the earnings announcement, the stock had already declined 18% in 2024, and it experienced a significant drop of 29.8% on August 11 after Q2 results [3] Competitive Landscape - Monday.com competes with other project management software companies such as Asana, Smartsheet, and Atlassian [4] - The company raised $574 million during its IPO in June 2021, with an initial stock price of $155 [4] Stock Ratings - Monday.com holds a Composite Rating of 53 out of a possible 99, indicating moderate performance relative to peers [4] - The stock has an Accumulation/Distribution Rating of D, suggesting heavy selling over the past 13 weeks [5]

Group 1 - U.S. stock futures are higher, with Nasdaq futures gaining approximately 1.5% [1] - Monday.Com Ltd is expected to report quarterly earnings of 88 cents per share, an increase from 85 cents per share year-over-year [2] - The consensus estimate for monday.com's quarterly revenue is $312.26 million, up from $251 million a year earlier [2] Group 2 - Monday.Com shares fell 2.6% to $184.70 in pre-market trading [2] - Metsera Inc shares dipped 15% to $70.68 in pre-market trading following Pfizer's $10 billion acquisition deal [4] - Ionis Pharmaceuticals Inc declined 11.5% to $65.00 after disclosing results from pivotal Phase 3 studies [4] - Other companies such as UniQure NV, Oscar Health Inc, Centene Corp, and Immunovant Inc also experienced declines in pre-market trading [4]

Group 1 - U.S. stock futures are higher, with Nasdaq futures gaining approximately 1.5% on Monday [1] - Monday.Com Ltd is expected to report quarterly earnings of 88 cents per share, an increase from 85 cents per share in the previous year [2] - The consensus estimate for monday.com's quarterly revenue is $312.26 million, up from $251 million a year earlier [2] Group 2 - Monday.Com shares fell 2.6% to $184.70 in pre-market trading [2] - Metsera Inc shares dipped 15% to $70.68 after Pfizer secured a $10 billion deal to acquire the company [4] - Ionis Pharmaceuticals Inc declined 11.5% to $65.00 following the disclosure of pivotal Phase 3 study results [4] - Other companies such as UniQure NV, Oscar Health Inc, Centene Corp, and Immunovant Inc also experienced declines in pre-market trading [4]

monday.com Ltd. (NASDAQ:MNDY) will release earnings results for the third quarter before the opening bell on Monday, Nov. 10.Analysts expect the Tel Aviv, Israel-based company to report quarterly earnings at 88 cents per share. That's up from 85 cents per share in the year-ago period. The consensus estimate for monday.com's quarterly revenue is $312.26 million, compared to $251 million a year earlier, according to data from Benzinga Pro.On Aug. 11, the company reported a second-quarter revenue growth of 27% ...

Core Viewpoint - monday.com Ltd. is set to release its third-quarter earnings on November 10, with expectations of increased earnings and revenue compared to the previous year [1]. Financial Performance - Analysts predict that monday.com will report earnings of 88 cents per share for the third quarter, up from 85 cents per share in the same period last year [1]. - The consensus estimate for quarterly revenue is $312.26 million, a significant increase from $251 million a year earlier [1]. - In the second quarter, the company reported a revenue growth of 27% year-on-year, reaching $299.01 million, surpassing the analyst consensus estimate of $293.54 million [2]. Stock Performance - Following the positive earnings report in the second quarter, shares of monday.com rose by 4.7%, closing at $189.59 [2]. Analyst Ratings - Wells Fargo initiated coverage with an Overweight rating and a price target of $260 for 2025 [5]. - Citigroup maintained a Buy rating and raised the price target from $326 to $332 for 2025 [5]. - Cantor Fitzgerald maintained an Overweight rating but reduced the price target from $286 to $257 for 2025 [5]. - Piper Sandler also maintained an Overweight rating, cutting the price target from $300 to $275 for 2025 [5]. - Goldman Sachs maintained a Buy rating while lowering the price target from $350 to $270 for 2025 [5].

Group 1: Company Performance - monday.com reported revenues of $299 million last quarter, exceeding analysts' expectations by 1.8% and showing a year-on-year growth of 26.6% [1] - The company added 258 enterprise customers paying more than $50,000 annually, bringing the total to 3,702 [1] - Analysts expect monday.com's revenue to grow 24.4% year on year to $312.4 million this quarter, with adjusted earnings projected at $0.88 per share [2] Group 2: Analyst Expectations - Analysts have generally reconfirmed their estimates over the last 30 days, indicating confidence in the company's performance heading into earnings [3] - monday.com has a history of exceeding Wall Street's expectations, beating revenue estimates by an average of 2.3% over the past two years [3] Group 3: Industry Context - Peers in the productivity software segment, such as Atlassian and Pegasystems, reported year-on-year revenue growth of 20.6% and 17.3% respectively, both beating analysts' expectations [4] - Investors in the productivity software segment have maintained steady positions, with monday.com shares up 2.2% over the last month, while the average analyst price target is $266.33 compared to the current share price of $189.15 [5]

Core Insights - The productivity software sector has seen increased demand due to rising employee costs and the shift to remote work, driving the need for tools that enhance corporate productivity [1] - The 17 tracked productivity software stocks reported a strong Q2, with revenues exceeding analysts' expectations by 2.9% and an average share price increase of 5.6% since the earnings results [2] monday.com Performance - monday.com reported revenues of $299 million for Q2, reflecting a year-on-year increase of 26.6% and surpassing analysts' expectations by 1.8% [4] - The company demonstrated strong performance with significant beats in both EBITDA and annual recurring revenue estimates, indicating effective growth strategies [4] - Despite the positive earnings report, monday.com's stock has declined by 26.6% since the announcement, currently trading at $182 [5] Pegasystems Performance - Pegasystems achieved revenues of $381.4 million in Q2, marking a 17.3% year-on-year increase and outperforming analysts' expectations by 8.5% [7] - The company had a notable quarter with substantial beats in both billings and EBITDA estimates, leading to a 3.9% increase in stock price since reporting, currently trading at $59.30 [8]

What Happened? Shares of work management platform monday.com (NASDAQ:MNDY) fell 5.4% in the morning session after a broad sell-off hit the technology sector, fueled by renewed concerns over high valuations and the potential disruption from artificial intelligence (AI). The decline was widespread, with major stock indexes retreating. The tech-heavy Nasdaq fell significantly as technology stocks became the heaviest weights on the market. The sell-off specifically hit software and semiconductor stocks. This ...